Pre- and Post-Pubertal Leptin Levels in Subjects Born Very Preterm and Full-Term Small for Gestational Age in Relation to Measurements of Adipose Tissue
Article Sidebar
Downloads
Submit your own article
Register as an author to reserve your spot in the next issue of the Medical Research Archives.
Author RegistrationJoin the Society
The European Society of Medicine is more than a professional association. We are a community. Our members work in countries across the globe, yet are united by a common goal: to promote health and health equity, around the world.
Join Europe’s leading medical society and discover the many advantages of membership, including free article publication.
MembershipMain Article Content
Abstract
Background: Children born with low birth weight may be at risk of developing the metabolic syndrome.
Aim: Determine body composition and metabolic profile with focus on adipose tissue and leptin from childhood to young adulthood in a cohort of subjects born very preterm with LBW or term-born small for gestational age (SGA) compared to controls.
Methods: This follow-up cohort study included 82 adults (57% women), mean age 21 (range 19-22) years. Seventy-four (90%) of these had taken part in a pre-pubertal study at age 9 years and were re-examined. The adult cohort comprised of subjects born very preterm (<30 gestational weeks) (n= 31) (preterm), born SGA (n=24) and full-term normal-weight controls (n= 27). Demographics including target height were collected. Adipose tissue was estimated by impedance. Fasting levels of glucose, c-peptide, leptin, insulin, insulin growth factor (IGF) binding protein (BP)-1, IGF-I and glucagon were determined.
Results: Preterm women weighed less (p<0.01) and had lower height SDS (p<0.05) compared with control women at follow-up. Preterm women had lower total adipose tissue percentage (24 (20–27) vs 29 (25–32) %, p=0.037), and trunk fat mass (19 (15–23) vs 26 (22–30)%, p=0.029) compared with control women, not seen in preterm men. Glucose or insulin did not differ between groups, but mean C-peptide was higher in SGA women compared with preterm women (p<0.05). Leptin levels did not differ between groups (p=0.86). Leptin was closely correlated with total adipose content in men (r= 0.79, p< 0.001) and in women (r= 0.84, p< 0.001). Leptin adjusted for adipose tissue was higher in all preterm compared with controls (p=0.017). In multiple regression analyses, 78% of the leptin variability was explained by adipose tissue percentage, insulin and gender (p<0.0001, n=76). In preterm men IGF-I was strongly correlated with adipose tissue percentage (r=0.77, p<0.001).
Conclusion: In young adulthood, preterm women weigh less, were shorter and had lower adipose tissue percentage, and all preterm had higher leptin levels adjusted for adipose tissue. We speculate that the higher leptin levels in relation to adipose tissue in preterm might serve as protection to enhance insulin sensitivity. The higher C-peptide could indicate peripheral insulin resistance in SGA women. IGF-I could be of special importance to adipose tissue in preterm men.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Fewtrell MS, Lucas A, Cole TJ, et al. Prematurity and reduced body fatness at 8-12 y of age. Am J Clin Nutr. 2004;80(2):436-440.
3. Kerkhof GF, Willemsen RH, Leunissen RW, et al. Health profile of young adults born preterm: negative effects of rapid weight gain in early life. J Clin Endocrinol Metab. 2012;97(12):4498-4506.
4. Breukhoven PE, Kerkhof GF, Willemsen RH, et al. Fat mass and lipid profile in young adults born preterm. J Clin Endocrinol Metab. 2012;97(4):1294-1302.
5. Sipola-Leppanen M, Vaarasmaki M, Tikanmaki M, et al. Cardiovascular risk factors in adolescents born preterm. Pediatrics. 2014;134(4):e1072-1081.
6. Jussinniemi L, Kulmala MK, Aakvik KAD, et al. Body composition in adults born preterm with very low birth weight. Pediatr Res. 2023.
7. Mi D, Fang H, Zhao Y, et al. Birth weight and type 2 diabetes: A meta-analysis. Exp Ther Med. 2017;14(6):5313-5320.
8. Kahn HS, Stein AD, Lumey LH. Prenatal environmental exposures that may influence beta-cell function or insulin sensitivity in middle age. J Dev Orig Health Dis. 2010;1(5):300-309.
9. Challa AS, Evagelidou EN, Cholevas VI, et al. Growth factors and adipocytokines in prepubertal children born small for gestational age: relation to insulin resistance. Diabetes care. 2009;32(4):714-719.
10. Hovi P, Andersson S, Eriksson JG, et al. Glucose regulation in young adults with very low birth weight. NEJM. 2007;356(20):2053-2063.
11. Dufour S, Petersen KF. Disassociation of liver and muscle insulin resistance from ectopic lipid accumulation in low-birth-weight individuals. J Clin Endocrinol Metab. 2011;96(12):3873-3880.
12. Kajantie E, Strang-Karlsson S, Hovi P, et al. Insulin sensitivity and secretory response in adults born preterm: the Helsinki Study of Very Low Birth Weight Adults. J Clin Endocrinol Metab. 2015;100(1):244-250.
13. Balasuriya CND, Stunes AK, Mosti MP, et al. Metabolic Outcomes in Adults Born Preterm With Very Low Birthweight or Small for Gestational Age at Term: A Cohort Study. J Clin Endocrinol Metab. 2018;103(12):4437-4446.
14. Kistner A, Rakow A, Legnevall L, et al. Differences in insulin resistance markers between children born small for gestational age or born preterm appropriate for gestational age. Acta Paediatr. 2012;101(12):1217-1224.
15. Araujo-Vilar D, Santini F. Diagnosis and treatment of lipodystrophy: a step-by-step approach. J Endocrinol Invest. 2019;42(1):61-73.
16. Kedikova SE, Sirakov MM, Boyadzhieva MV. Leptin levels and adipose tissue percentage in adolescents with polycystic ovary syndrome. Gynecol Endocrinol. 2013;29(4):384-387.
17. Huke V, Rudloff S, Brugger M, et al. Prematurity is not associated with intra-abdominal adiposity in 5- to 7-year-old children. J Pediatr. 2013;163(5):1301-1306.
18. Gianni ML, Mora S, Roggero P, et al. Regional fat distribution in children born preterm evaluated at school age. J Pediatr Gastroenterol Nutr. 2008;46(2):232-235.
19. Kistner A, Vanpee M, Hall K. Leptin may enhance hepatic insulin sensitivity in children and women born small for gestational age. Endocr Connect. 2013;2(1):38-49.
20. Stefanou N, Papanikolaou V, Furukawa Y, et al. Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase. BMC cancer. 2010;10:442.
21. Niklasson A, Albertsson-Wikland K. Continuous growth reference from 24th week of gestation to 24 months by gender. BMC pediatrics. 2008;8:8.
22. Wikland KA, Luo ZC, Niklasson A, et al. Swedish population-based longitudinal reference values from birth to 18 years of age for height, weight and head circumference. Acta Paediatr. 2002;91(7):739-754.
23. Povoa G, Roovete A, Hall K. Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta endocrinol. 1984;107(4):563-570.
24. Lewitt MS, Hilding A, Brismar K, et al. IGF-binding protein 1 and abdominal obesity in the development of type 2 diabetes in women. EJE. 2010;163(2):233-242.
25. Banauch D, Brummer W, Ebeling W, et al. [A glucose dehydrogenase for the determination of glucose concentrations in body fluids (author's transl)]. Zeitschrift fur klinische Chemie und klinische Biochemie. 1975;13(3):101-107.
26. Bang P, Eriksson U, Sara V, et al. Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. Acta endocrinol. 1991;124(6):620-629.
27. Grinspoon S, Gulick T, Askari H, et al. Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab. 1996;81(11):3861-3863.
28. Marques-Oliveira GH, Silva TM, Lima WG, et al. Insulin as a hormone regulator of the synthesis and release of leptin by white adipose tissue. Peptides. 2018;106:49-58.
29. Bortolotto CC, Santos IS, Dos Santos Vaz J, et al. Prematurity and body composition at 6, 18, and 30 years of age: Pelotas (Brazil) 2004, 1993, and 1982 birth cohorts. BMC Public Health. 2021;21(1):321.
30. de Jong M, Cranendonk A, van Weissenbruch MM. Components of the metabolic syndrome in early childhood in very-low-birth-weight infants and term small and appropriate for gestational age infants. Pediatric research. 2015;78(4):457-461.
31. Dyck DJ. Adipokines as regulators of muscle metabolism and insulin sensitivity. Appl Physiol Nutr Metab. 2009;34(3):396-402.
32. Yadav A, Kataria MA, Saini V, et al. Role of leptin and adiponectin in insulin resistance. Clin Chim Acta. 2013;417:80-84.
33. Jaquet D, Gaboriau A, Czernichow P, et al. Relatively low serum leptin levels in adults born with intra-uterine growth retardation. Int J Obes Relat Metab Disord. 2001;25(4):491-495.
34. Utzschneider KM, Younes N, Rasouli N, et al. Association of glycemia with insulin sensitivity and beta-cell function in adults with early type 2 diabetes on metformin alone. J Diabetes Complications. 2021;35(5):107912.
35. Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia. 1992;35(7):595-601.
36. Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372(6505):425-432.
37. Ali AT, Hochfeld WE, Myburgh R, et al. Adipocyte and adipogenesis. Eur J Cell Biol. 2013;92(6-7):229-236.
38. Andersen M, Brixen K, Hagen C, et al. Positive associations between serum levels of IGF-I and subcutaneous fat depots in young men. The Odense Androgen Study. Growth Horm IGF Res. 2012;22(3-4):139-145.
39. Ruys CA, van de Lagemaat M, Lafeber HN, et al. Leptin and IGF-1 in relation to body composition and bone mineralization of preterm-born children from infancy to 8 years. Clin Endocrinol (Oxf). 2018;89(1):76-84.
40. Kotronen A, Lewitt M, Hall K, et al. Insulin-like growth factor binding protein 1 as a novel specific marker of hepatic insulin sensitivity. J Clin Metab Endocrinol 2008;93(12):4867-4872.
41. Lewitt MS, Hilding A, Ostenson CG, et al. Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men. Diabetologia. 2008;51(7):1135-1145.